[HTML][HTML] Neuroimmune signaling in alcohol use disorder

EK Erickson, EK Grantham, AS Warden… - Pharmacology …, 2019 - Elsevier
Alcohol use disorder (AUD) is a widespread disease with limited treatment options.
Targeting the neuroimmune system is a new avenue for developing or repurposing effective …

Neuroimmune mechanisms as novel treatment targets for substance use disorders and associated comorbidities

MD Namba, JM Leyrer-Jackson, EK Nagy… - Frontiers in …, 2021 - frontiersin.org
Recent studies examining the neurobiology of substance abuse have revealed a significant
role of neuroimmune signaling as a mechanism through which drugs of abuse induce …

Immune treatments for alcohol use disorder: A translational framework

LR Meredith, EM Burnette, EN Grodin, MR Irwin… - Brain, behavior, and …, 2021 - Elsevier
While the immune system is essential for survival, an excessive or prolonged inflammatory
response, such as that resulting from sustained heavy alcohol use, can damage the host …

Medications for alcohol use disorders: An overview

M Akbar, M Egli, YE Cho, BJ Song… - Pharmacology & …, 2018 - Elsevier
Patients who suffer from alcohol use disorders (AUDs) usually go through various socio-
behavioral and pathophysiological changes that take place in the brain and other organs …

Rat animal models for screening medications to treat alcohol use disorders

RL Bell, SR Hauser, T Liang, Y Sari… - …, 2017 - Elsevier
The purpose of this review is to present animal research models that can be used to screen
and/or repurpose medications for the treatment of alcohol abuse and dependence. The …

Fenofibrate decreases ethanol-induced neuroinflammation and oxidative stress and reduces alcohol relapse in rats by a PPAR-α-dependent mechanism

C Ibáñez, T Acuña, ME Quintanilla, D Pérez-Reytor… - Antioxidants, 2023 - mdpi.com
High ethanol consumption triggers neuroinflammation, implicated in sustaining chronic
alcohol use. This inflammation boosts glutamate, prompting dopamine release in reward …

Therapeutic potential of peroxisome proliferator-activated receptor (PPAR) agonists in substance use disorders: a synthesis of preclinical and human evidence

J Matheson, B Le Foll - Cells, 2020 - mdpi.com
Targeting peroxisome proliferator-activated receptors (PPARs) has received increasing
interest as a potential strategy to treat substance use disorders due to the localization of …

A review on the reciprocal interactions between neuroinflammatory processes and substance use and misuse, with a focus on alcohol misuse

A Gano, T Deak, RM Pautassi - The American journal of drug and …, 2023 - Taylor & Francis
Background: The last decade has witnessed a surge of findings implicating
neuroinflammatory processes as pivotal players in substance use disorders. The …

Its complicated: The relationship between alcohol and microglia in the search for novel pharmacotherapeutic targets for alcohol use disorders

JK Melbourne, KR Thompson, H Peng… - Progress in Molecular …, 2019 - Elsevier
Alcohol use disorder (AUD) is a chronic relapsing disorder with wide-ranging health
consequences. Alcohol targets the central nervous system producing neurodegeneration …

The impact of single and combined PPAR-α and PPAR-γ activation on the neurological outcomes following cerebral ischemia reperfusion

AHF Shehata, ASF Ahmed, AB Abdelrehim, GH Heeba - Life sciences, 2020 - Elsevier
Aim The neuronal damage and accompanied functional deficits induced by cerebral
ischemia are among the most common causes of disabilities in adults. Activation of subtypes …